IP Library Granted Patent US 6,930,127
Granted Patent B2
US 6,930,127 · App. 10/465,293 · Granted Aug 16, 2005

Veterinary treatment of ophthalmic disease in animals using topical tacrolimus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,930,127
App. No.
10/465,293
Filed
Jun 18, 2003
Granted
Aug 16, 2005
Kind
B2
Art Unit
1614
USPC
514/291
Abstract

A composition and method for veterinary treatment of ophthalmic immune-mediated inflammatory conditions in animals such as conjunctival disorders of the third eyelid, keratoconjunctivitis sicca (KCS), chronic superficial keratitis (CSK), feline eosinophilic keratoconjunctivitis, allergic conjunctivitis, blepharoconjunctivitis, ocular rosacea, viral conjunctivitis, uveitis and phacoanaphylactic endophthalmitis involves the topical administration of tacrolimus to the eye in a pharmaceutically acceptable lubricant vehicle. The composition of the invention includes about 0.00001% to 10.0% tacrolimus by weight in a pharmaceutically acceptable oil-based solution or ointment and may be administered to the third eyelid of an affected animal.

Claims (6)

1. A method of treating pannus in canines having said disease and comprising the steps of:

a) providing a quantity of a composition consisting essentially of an effective amount of tacrolimus in a pharmaceutically acceptable non-aqueous lubricant vehicle; and

b) administering a quantity of said composition to the third eyelid of an affected canine.

2. The method as set forth in claim 1 , wherein:

a) said tacrolimus is present in a concentration of from about 0.00001% to about 10.0% by weight.

3. The method as set forth in claim 1 , wherein said lubricating vehicle is selected from the group consisting essentially of corn oil, olive oil, mineral oil, cottonseed oil, sesame oil, canola oil, peanut oil, safflower oil, sunflower oil, polyoxethylated castor oil, petrolatum, mineral oil or mixtures thereof.

Assignments (5)
SECURITY INTEREST Recorded Oct 19, 2022
From: EVP PHARMACEUTICALS, INC.; SMARTPAK EQUINE, LLC
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 061473/0364 →
SECURITY INTEREST Recorded Oct 19, 2022
From: EVP PHARMACEUTICALS, INC.; SMARTPAK EQUINE, LLC
To: OWL ROCK CAPITAL CORPORATION
Reel/Frame 061473/0435 →
RELEASE OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (048263/0380) Recorded Oct 13, 2022
From: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
To: EVP PHARMACEUTICALS, INC. (FORMERLY KNOWN AS EATON VETERINARY LABORATORIES, INC.)
Reel/Frame 061680/0840 →
SECURITY INTEREST Recorded Feb 7, 2019
From: EVP PHARMACEUTICALS, INC. (FORMERLY KNOWN AS EATON VETERINARY LABORATORIES, INC.)
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048263/0380 →
CHANGE OF NAME Recorded Apr 3, 2018
From: EATON VETERINARY PHARMACEUTICAL, INC.
To: EVP PHARMACEUTICALS, INC.
Reel/Frame 045830/0248 →